- Home
- CBUS vs STRO Comparison
CBUS vs STRO Comparison
Compare CBUS & STRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CBUS
- STRO
- Stock Information
- Founded
- CBUS 2010
- STRO 2003
- Country
- CBUS United States
- STRO United States
- Employees
- CBUS N/A
- STRO N/A
- Industry
- CBUS Agricultural Chemicals
- STRO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CBUS Industrials
- STRO Health Care
- Exchange
- CBUS Nasdaq
- STRO Nasdaq
- Market Cap
- CBUS 72.0M
- STRO 69.1M
- IPO Year
- CBUS 2017
- STRO 2018
- Fundamental
- Price
- CBUS $1.28
- STRO $1.06
- Analyst Decision
- CBUS Strong Buy
- STRO Hold
- Analyst Count
- CBUS 3
- STRO 7
- Target Price
- CBUS $22.00
- STRO $1.97
- AVG Volume (30 Days)
- CBUS 210.3K
- STRO 519.9K
- Earning Date
- CBUS 11-06-2025
- STRO 08-07-2025
- Dividend Yield
- CBUS N/A
- STRO N/A
- EPS Growth
- CBUS N/A
- STRO N/A
- EPS
- CBUS N/A
- STRO N/A
- Revenue
- CBUS $4,846,000.00
- STRO $104,473,000.00
- Revenue This Year
- CBUS $18.23
- STRO $65.42
- Revenue Next Year
- CBUS $62.65
- STRO N/A
- P/E Ratio
- CBUS N/A
- STRO N/A
- Revenue Growth
- CBUS 63.66
- STRO N/A
- 52 Week Low
- CBUS $1.20
- STRO $0.52
- 52 Week High
- CBUS $6.10
- STRO $4.80
- Technical
- Relative Strength Index (RSI)
- CBUS 39.59
- STRO 71.61
- Support Level
- CBUS $1.20
- STRO $0.95
- Resistance Level
- CBUS $1.41
- STRO $1.07
- Average True Range (ATR)
- CBUS 0.08
- STRO 0.09
- MACD
- CBUS 0.00
- STRO 0.02
- Stochastic Oscillator
- CBUS 33.33
- STRO 68.42
About CBUS Cibus Inc.
Cibus Inc is a biotechnology company. The company develops and commercializes a proprietary gene-editing technology, Rapid Trait Development System that integrates crop specific cell biology platforms with a series of gene editing technologies. The company's primary business is the development of plant traits that help address specific productivity or yield challenges in farming such as traits addressing plant agronomy, disease, insects, weeds, nutrient-use, or the climate.
About STRO Sutro Biopharma Inc.
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. The company also pipeline contains STRO-004, STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.